694 related articles for article (PubMed ID: 30134818)
21. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.
Brenu EW; van Driel ML; Staines DR; Ashton KJ; Hardcastle SL; Keane J; Tajouri L; Peterson D; Ramos SB; Marshall-Gradisnik SM
J Transl Med; 2012 May; 10():88. PubMed ID: 22571715
[TBL] [Abstract][Full Text] [Related]
22. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S
Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393
[TBL] [Abstract][Full Text] [Related]
23. Identification of transient receptor potential melastatin 3 proteotypic peptides employing an efficient membrane protein extraction method for natural killer cells.
Magawa CT; Eaton-Fitch N; Balinas C; Sasso EM; Thapaliya K; Barnden L; Maksoud R; Weigel B; Rudd PA; Herrero LJ; Marshall-Gradisnik S
Front Physiol; 2022; 13():947723. PubMed ID: 36213251
[No Abstract] [Full Text] [Related]
24. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.
Eaton-Fitch N; du Preez S; Cabanas H; Staines D; Marshall-Gradisnik S
Syst Rev; 2019 Nov; 8(1):279. PubMed ID: 31727160
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study.
Querec TD; Lin JS; Chen Y; Helton B; Kogelnik AM; Klimas NG; Peterson DL; Bateman L; Lapp C; Podell RN; Natelson BH; Unger ER;
J Transl Med; 2023 Apr; 21(1):242. PubMed ID: 37013608
[TBL] [Abstract][Full Text] [Related]
26. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Johnston S; Staines D; Klein A; Marshall-Gradisnik S
BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Brenu EW; Ashton KJ; van Driel M; Staines DR; Peterson D; Atkinson GM; Marshall-Gradisnik SM
J Affect Disord; 2012 Dec; 141(2-3):261-9. PubMed ID: 22572093
[TBL] [Abstract][Full Text] [Related]
28. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
Front Immunol; 2019; 10():796. PubMed ID: 31057538
[TBL] [Abstract][Full Text] [Related]
29. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Rivas JL; Palencia T; Fernández G; García M
Front Immunol; 2018; 9():1028. PubMed ID: 29867995
[TBL] [Abstract][Full Text] [Related]
30. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
Petty RD; McCarthy NE; Le Dieu R; Kerr JR
PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895
[TBL] [Abstract][Full Text] [Related]
32. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
Front Immunol; 2020; 11():582330. PubMed ID: 33329554
[TBL] [Abstract][Full Text] [Related]
33. Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.
Drews A; Mohr F; Rizun O; Wagner TF; Dembla S; Rudolph S; Lambert S; Konrad M; Philipp SE; Behrendt M; Marchais-Oberwinkler S; Covey DF; Oberwinkler J
Br J Pharmacol; 2014 Feb; 171(4):1019-32. PubMed ID: 24251620
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
Chacko A; Staines DR; Johnston SC; Marshall-Gradisnik SM
Gene Regul Syst Bio; 2016; 10():85-93. PubMed ID: 27594784
[TBL] [Abstract][Full Text] [Related]
35. Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Ramos S; Brenu E; Broadley S; Kwiatek R; Ng J; Nguyen T; Freeman S; Staines D; Marshall-Gradisnik S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):300-305. PubMed ID: 27001659
[TBL] [Abstract][Full Text] [Related]
36. Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells.
Son GY; Yang YM; Park WS; Chang I; Shin DM
J Dent Res; 2015 Mar; 94(3):473-81. PubMed ID: 25595364
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Ramos S; Staines D; Marshall-Gradisnik S
J Transl Med; 2015 Sep; 13():299. PubMed ID: 26370228
[TBL] [Abstract][Full Text] [Related]
38. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.
Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM
Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometry.
Balinas C; Cabanas H; Staines D; Marshall-Gradisnik S
BMC Immunol; 2019 May; 20(1):14. PubMed ID: 31077146
[TBL] [Abstract][Full Text] [Related]
40. Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Maya J
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
